The EPA wants to study the product further after it found that the company's Dow AgroSciences unit claimed the two active ingredients work better together, according to court documents. "The information suggests that EPA's analysis may have understated the phytotoxicity of the product," the EPA said in the court filing. Dow Chemical said it has sent the EPA all...» Read More
Chemical and plastics maker Basell said on Tuesday it would buy Lyondell Chemical in a deal valued at about $12.14 billion, giving Basell access to a key raw material and Lyondell's refining capacity.
Paint and chemicals maker Rohm & Haas said after U.S. markets closed Monday that its board approved a $2 billion stock buyback plan that will be executed in two stages.
Chemicals maker Huntsman agreed to a $6.5 billion buyout offer from an affiliate of Apollo Management on Thursday, terminating an earlier deal to sell itself at a lower price to a Dutch company.
Apollo Management raised its offer for chemical company Huntsman by 2.8% to $6.5 billion Monday, widening the premium over rival suitor Basell.
A group of investors led by private equity firm CVC Capital Partners said Monday it bid 1.5 billioneuros ($2 billion) for chemicals distributor Univar with approval from Univar's boards.
U.S. chemical company Huntsman said Friday the $6 billion buyout offer from Apollo Management's Hexion Specialty Chemicals is superior to the previously accepted deal offered by Basell.
A bounce back in takeover activity, including Blackstone's bold $26 billion bid for Hilton, is giving strength to stock futures ahead of the opening on the second leg of this holiday-shortened week.
U.S. private equity firm Apollo Management unveiled a $6 billion bid proposal for Huntsman on Wednesday, 8% higher than a deal accepted by the U.S. chemical company last week.
Chemicals maker Basell said Tuesday it has agreed to buy U.S. chemical company Huntsman for $5.6 billion excluding debt, in a bid to strengthen its position as a global chemicals group.
Shares in Standard Chartered fell 1.2% Wednesday despite an upbeat trading statement from the global bank, as investors cashed in on the stock's recent strong performance, according to Keefe, Bruyette and Woods.
German drugs and chemicals group Bayer raised its profit outlook on strong sales of drugs such as multiple sclerosis treatment Betaseron and higher savings from the integration of Schering, sending its shares higher.
Britain's Imperial Chemical Industries has rejected a 7.2 billion-pound ($14.2 billion) bid approach from Dutch chemicals group Akzo Nobel, saying it undervalued the company.
If speculation that China will repeal a tax rebate for its soda ash exporters is true, that could mean a profit windfall for American firm FMC.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Shares in BAE Systems fell in response to reports from the British press that Europe's largest defense company paid 1 billion pounds ($2 billion) over a decade to a Saudi prince to seal one of Britain's biggest-ever arms export contracts.
Shares in Airbus owner EADS fell 0.9%, as details about the European planemaker's Power8 restructuring program were due to released to its unions Tuesday.
Shares in Alliance Boots fell 0.2% on a report from the Financial Times that the retail chain is seeking blocking rights for a takeover from Kohlberg Kravis Roberts valued at about $21.87 billion.
Will it be Nancy, or Serge or Steven--or maybe someone else winning a $1,000,000? The Million Dollar Portfolio Challenge is winding down today. Trading stops at the closing bell, so what happens will depend on who picked the best stock or stocks--as very little money separates the top three contenders. But as we said, there could be someone back in the pack, that's picked the best stock to leapfrog over the big three.
Scott Cole is not exactly a stranger when it comes to trading. That's probably why he's one of the twenty finalists competing for the $1,000,000 prize in our CNBC Million Dollar Portfolio Challenge. Scott is an investment fund manager with a BA from Northwestern University and has a MBA from Stanford University. He's married with two young children.
Good morning all. We're starting this last day on the rough side as more than half of our Million Dollar contestants lost ground Thursday in a volatile market. All of our finalists are fully invested, with the exception of #15, Chuck Chow who is all in cash. Nancy Beaumont holds first place for the 4th straight day on the 9% gain of Gymboree. Nancy may hold onto the top spot with her almost all-in trade on Verigy, a Singapore-based maker of test systems for the semiconductor industry, which beat estimates after the bell Thursday. Verigy was up almost 10% in extended hours.
The U.S. securities regulator is probing whether two Dow Chemical executives engaged in unauthorized talks to sell the company, according to a source close to the matter.